FR2878164B1 - Nouvelles utilisations de ligands de la neogenine - Google Patents

Nouvelles utilisations de ligands de la neogenine

Info

Publication number
FR2878164B1
FR2878164B1 FR0412362A FR0412362A FR2878164B1 FR 2878164 B1 FR2878164 B1 FR 2878164B1 FR 0412362 A FR0412362 A FR 0412362A FR 0412362 A FR0412362 A FR 0412362A FR 2878164 B1 FR2878164 B1 FR 2878164B1
Authority
FR
France
Prior art keywords
seq
amino acids
activity
fragment
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0412362A
Other languages
English (en)
Other versions
FR2878164A1 (fr
Inventor
Jean Plouet
Monica Alemany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
I V S INST DES VAISSEAUX ET DU
Centre National de la Recherche Scientifique CNRS
Original Assignee
I V S INST DES VAISSEAUX ET DU
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0412362A priority Critical patent/FR2878164B1/fr
Application filed by I V S INST DES VAISSEAUX ET DU, Centre National de la Recherche Scientifique CNRS filed Critical I V S INST DES VAISSEAUX ET DU
Priority to CA002587921A priority patent/CA2587921A1/fr
Priority to US11/791,274 priority patent/US7999072B2/en
Priority to JP2007542043A priority patent/JP5089397B2/ja
Priority to EP05820955.2A priority patent/EP1814579B1/fr
Priority to PCT/FR2005/002898 priority patent/WO2006054000A2/fr
Priority to EP10185304.2A priority patent/EP2322206A3/fr
Priority to EP10185297A priority patent/EP2329838A3/fr
Publication of FR2878164A1 publication Critical patent/FR2878164A1/fr
Application granted granted Critical
Publication of FR2878164B1 publication Critical patent/FR2878164B1/fr
Priority to US13/171,756 priority patent/US8168593B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR0412362A 2004-11-22 2004-11-22 Nouvelles utilisations de ligands de la neogenine Expired - Fee Related FR2878164B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0412362A FR2878164B1 (fr) 2004-11-22 2004-11-22 Nouvelles utilisations de ligands de la neogenine
US11/791,274 US7999072B2 (en) 2004-11-22 2005-11-22 Mutated netrin-4, fragments thereof and their use as medicines
JP2007542043A JP5089397B2 (ja) 2004-11-22 2005-11-22 変異ネトリン４、その断片及びこれらの薬剤としての使用
EP05820955.2A EP1814579B1 (fr) 2004-11-22 2005-11-22 Netrine 4 mutee, ses fragments et leur utilisation comme medicaments
CA002587921A CA2587921A1 (fr) 2004-11-22 2005-11-22 Netrine 4 mutee, ses fragments et leur utilisation comme medicaments
PCT/FR2005/002898 WO2006054000A2 (fr) 2004-11-22 2005-11-22 Netrine 4 mutee, ses fragments et leur utilisation comme medicaments
EP10185304.2A EP2322206A3 (fr) 2004-11-22 2005-11-22 Nétrine 1 mutée, ses fragments et leur utilisation comme médicaments
EP10185297A EP2329838A3 (fr) 2004-11-22 2005-11-22 Nétrine 4 mutée, ses fragments et leur utilisation comme médicaments
US13/171,756 US8168593B2 (en) 2004-11-22 2011-06-29 Mutated netrin-4, fragments thereof and their use as medicines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0412362A FR2878164B1 (fr) 2004-11-22 2004-11-22 Nouvelles utilisations de ligands de la neogenine

Publications (2)

Publication Number Publication Date
FR2878164A1 FR2878164A1 (fr) 2006-05-26
FR2878164B1 true FR2878164B1 (fr) 2007-03-23

Family

ID=34952855

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0412362A Expired - Fee Related FR2878164B1 (fr) 2004-11-22 2004-11-22 Nouvelles utilisations de ligands de la neogenine

Country Status (1)

Country Link
FR (1) FR2878164B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109517807A (zh) * 2018-11-20 2019-03-26 暨南大学 一种心脏血管靶向的噬菌体载体及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740841B1 (en) * 2000-01-28 2010-06-22 Sunnybrook Health Science Center Therapeutic method for reducing angiogenesis
EP1263767A4 (fr) * 2000-02-29 2004-12-15 Gen Hospital Corp Netrine beta et ses utilisations

Also Published As

Publication number Publication date
FR2878164A1 (fr) 2006-05-26

Similar Documents

Publication Publication Date Title
AR047347A1 (es) Miembros de la familia cry9 de bacillus
CY1110959T1 (el) Εκφραση βιολογικως δραστικων πολυπεπτιδιων σε λεμνα ("duckweed")
KR960705850A (ko) 사람 쿠니즈형 프로테아제 저해인자(human kunitz-type protease inhibitors)
NO20013801L (no) Ny karbonyl reduktase, gen derav og metoder for anvendelse av det samme
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
ATE477272T1 (de) Verwendung von stefin a als gerüstprotein
BR0309401A (pt) polinucleotìdeo isolado, vetor de expressão, célula cultivada, método para produzir polipeptìdeos, e um anticorpo para um polipeptìdeo, e, anticorpo
ATE404673T1 (de) Bakteriocin gegen listeria
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
ID29693A (id) Rangkaian-rangkaian nukleotida yang mengkode gen dapc dan proses untuk memproduksi l-lisin
FR2878164B1 (fr) Nouvelles utilisations de ligands de la neogenine
ATE508189T1 (de) Zur beschleunigung der genexpressionbei einer mässig niedrigen temperatur fähige sequenz
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
FI953688A0 (fi) Kasvinsuojeluominaisuudet omaava proteiini
FR2910003B1 (fr) Nouveaux peptides et polypeptides a stabilite amelioree utiles dans la regeneration du systeme nerveux
Rodgers et al. Activation of coagulation factor V by calcium-dependent proteinase
DE60234847D1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
ATE346941T1 (de) Protein-disulfidisomerase-gen eines methylotrophen hefestammes
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
GB2441941A (en) An isolated recombinant vaccinia virus complement control protein (HRVCP) polypeptide
Abu-Abed Kinetic and x-ray diffraction studies of the H91N mutant of duck delta II crystallin.
DE50211988D1 (de) Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren
DE59914878D1 (de) Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika
FR2857969B1 (fr) Peptide inhibiteur de la traduction des proteines et ses utilisations pour le controle de la traduction des proteines
Rydzewski Angiotensin II regulates the expression of extracellular protease inhibitors in the central nervous system.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070731